AU2003258134A1 - Lung cancer target proteins and use thereof - Google Patents

Lung cancer target proteins and use thereof

Info

Publication number
AU2003258134A1
AU2003258134A1 AU2003258134A AU2003258134A AU2003258134A1 AU 2003258134 A1 AU2003258134 A1 AU 2003258134A1 AU 2003258134 A AU2003258134 A AU 2003258134A AU 2003258134 A AU2003258134 A AU 2003258134A AU 2003258134 A1 AU2003258134 A1 AU 2003258134A1
Authority
AU
Australia
Prior art keywords
lung cancer
target proteins
cancer target
proteins
lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003258134A
Other versions
AU2003258134A8 (en
Inventor
Stephen Hoffman
Gangadharan Subramanian
Ruobing Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Biosystems Inc
Original Assignee
Applera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applera Corp filed Critical Applera Corp
Publication of AU2003258134A1 publication Critical patent/AU2003258134A1/en
Publication of AU2003258134A8 publication Critical patent/AU2003258134A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003258134A 2002-08-09 2003-08-08 Lung cancer target proteins and use thereof Abandoned AU2003258134A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40205702P 2002-08-09 2002-08-09
US60/402,057 2002-08-09
PCT/US2003/024698 WO2004015390A2 (en) 2002-08-09 2003-08-08 Lung cancer target proteins and use thereof

Publications (2)

Publication Number Publication Date
AU2003258134A1 true AU2003258134A1 (en) 2004-02-25
AU2003258134A8 AU2003258134A8 (en) 2004-02-25

Family

ID=31715780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003258134A Abandoned AU2003258134A1 (en) 2002-08-09 2003-08-08 Lung cancer target proteins and use thereof

Country Status (2)

Country Link
AU (1) AU2003258134A1 (en)
WO (1) WO2004015390A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026135A1 (en) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to MHC molecules
ES2536465T3 (en) 2008-10-01 2015-05-25 Immatics Biotechnologies Gmbh Composition of tumor-associated and cancer-related peptides for the treatment of glioblastoma (GBM) and other cancers
GB0904355D0 (en) * 2009-03-13 2009-04-29 Imp Innovations Ltd Biological materials and uses thereof
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
US20220002343A1 (en) * 2018-11-07 2022-01-06 Follicum Ab Peptide fragments for treatment of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554724A (en) * 1994-03-24 1996-09-10 University Of Leiden Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof

Also Published As

Publication number Publication date
WO2004015390A2 (en) 2004-02-19
AU2003258134A8 (en) 2004-02-25
WO2004015390A3 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
AU2003215460A1 (en) Cancer associated protein kinases and their uses
AU2003228269A1 (en) Phosphorylated proteins and uses related thereto
AU2003212162A1 (en) Cancer associated protein phosphatases and their uses
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003258134A1 (en) Lung cancer target proteins and use thereof
AU2003227861A1 (en) Protein involved in cancer
AU2003207628A1 (en) Structural and cytoskeleton-associated proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2003283339A1 (en) Cancer therapy determination
AU2003235096A1 (en) Novel protein and dna thereof
AU2003209886A1 (en) Cancer associated araf1 protein kinase and its uses
AU2003292774A1 (en) Novel proteins and use thereof
AU2003280992A1 (en) Novel proteins and use thereof
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003218029A1 (en) Methods of identifying target polypeptides
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003258658A1 (en) Improved dna and proteins
AU2003262080A1 (en) Novel protein and dna thereof
AU2003300785A1 (en) Carbohydrate-associated proteins
AU2003267475A1 (en) Tumor targeting agents and uses thereof
AU2002335297A1 (en) Tumor tag and the use thereof
AU2003263751A1 (en) Novel proteins and their uses
AU2003904023A0 (en) Protein fragments and uses thereof ii
AU2003265814A1 (en) Aw755252-interacting proteins and use thereof
AU2003229752A1 (en) Human rhomboid-related protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase